Literature DB >> 17893321

Serum withdrawal-induced accumulation of phosphoinositide 3-kinase lipids in differentiating 3T3-L6 myoblasts: distinct roles for Ship2 and PTEN.

Adel Mandl1, Deborah Sarkes, Valerie Carricaburu, Vanessa Jung, Lucia Rameh.   

Abstract

Phosphoinositide 3-kinase (PI3K) activation and synthesis of phosphatidylinositol-3,4-bisphosphate (PI-3,4-P2) and phosphatidylinositol-3,4,5-trisphosphate (PI-3,4,5-P3) lipids mediate growth factor signaling that leads to cell proliferation, migration, and survival. PI3K-dependent activation of Akt is critical for myoblast differentiation induced by serum withdrawal, suggesting that in these cells PI3K signaling is activated in an unconventional manner. Here we investigate the mechanisms by which PI3K signaling and Akt are regulated during myogenesis. We report that PI-3,4-P2 and PI-3,4,5-P3 accumulated in the plasma membranes of serum-starved 3T3-L6 myoblasts due to de novo synthesis and increased lipid stability. Surprisingly, only newly synthesized lipids were capable of activating Akt. Knockdown of the lipid phosphatase PTEN moderately increased PI3K lipids but significantly increased Akt phosphorylation and promoted myoblast differentiation. Knockdown of the lipid phosphatase Ship2, on the other hand, dramatically increased the steady-state levels of PI-3,4,5-P3 but did not affect Akt phosphorylation and increased apoptotic cell death. Together, these results reveal the existence of two distinct pools of PI3K lipids in differentiating 3T3-L6 myoblasts: a pool of nascent lipids that is mainly dephosphorylated by PTEN and is capable of activating Akt and promoting myoblast differentiation and a stable pool that is dephosphorylated by Ship2 and is unable to activate Akt.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17893321      PMCID: PMC2169165          DOI: 10.1128/MCB.00756-07

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  37 in total

Review 1.  Protein kinases as mediators of phosphoinositide 3-kinase signaling.

Authors:  A Toker
Journal:  Mol Pharmacol       Date:  2000-04       Impact factor: 4.436

2.  Identification and quantification of polyphosphoinositides produced in response to platelet-derived growth factor stimulation.

Authors:  L A Serunian; K R Auger; L C Cantley
Journal:  Methods Enzymol       Date:  1991       Impact factor: 1.600

3.  The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways.

Authors:  S A Coolican; D S Samuel; D Z Ewton; F J McWade; J R Florini
Journal:  J Biol Chem       Date:  1997-03-07       Impact factor: 5.157

4.  Phosphatidylinositol 3-kinase inhibitors block differentiation of skeletal muscle cells.

Authors:  P Kaliman; F Viñals; X Testar; M Palacín; A Zorzano
Journal:  J Biol Chem       Date:  1996-08-09       Impact factor: 5.157

5.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

6.  Overexpression of SH2-containing inositol phosphatase 2 results in negative regulation of insulin-induced metabolic actions in 3T3-L1 adipocytes via its 5'-phosphatase catalytic activity.

Authors:  T Wada; T Sasaoka; M Funaki; H Hori; S Murakami; M Ishiki; T Haruta; T Asano; W Ogawa; H Ishihara; M Kobayashi
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

7.  Insulin-like growth factor-mediated muscle differentiation: collaboration between phosphatidylinositol 3-kinase-Akt-signaling pathways and myogenin.

Authors:  J Tureckova; E M Wilson; J L Cappalonga; P Rotwein
Journal:  J Biol Chem       Date:  2001-08-10       Impact factor: 5.157

8.  Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation.

Authors:  J Wang; K Walsh
Journal:  Science       Date:  1996-07-19       Impact factor: 47.728

Review 9.  PTEN function: how normal cells control it and tumour cells lose it.

Authors:  Nick R Leslie; C Peter Downes
Journal:  Biochem J       Date:  2004-08-15       Impact factor: 3.857

10.  SH2-containing inositol phosphatase 2 predominantly regulates Akt2, and not Akt1, phosphorylation at the plasma membrane in response to insulin in 3T3-L1 adipocytes.

Authors:  Toshiyasu Sasaoka; Tsutomu Wada; Kazuhito Fukui; Shihou Murakami; Hajime Ishihara; Ryo Suzuki; Kazuyuki Tobe; Takashi Kadowaki; Masashi Kobayashi
Journal:  J Biol Chem       Date:  2004-01-26       Impact factor: 5.157

View more
  18 in total

1.  Molecular characterization, expression pattern, and association analysis with carcass traits of the porcine SHIP2 gene.

Authors:  Qi Xiong; Jin Chai; Changyan Deng; Siwen Jiang; Xiaofeng Li; Xiaojun Suo; Nian Zhang; Qianping Yang; Yang Liu; Rong Zheng; Mingxin Chen
Journal:  Mol Cell Biochem       Date:  2011-09-21       Impact factor: 3.396

2.  Developmental expression of a Trypanosoma cruzi phosphoinositide-specific phospholipase C in amastigotes and stimulation of host phosphoinositide hydrolysis.

Authors:  Vicente de Paulo Martins; Melina Galizzi; Maria Laura Salto; Roberto Docampo; Silvia N J Moreno
Journal:  Infect Immun       Date:  2010-07-19       Impact factor: 3.441

3.  IQGAP1 makes PI(3)K signalling as easy as PIP, PIP2, PIP3.

Authors:  Lucia E Rameh; Ashley M Mackey
Journal:  Nat Cell Biol       Date:  2016-11-29       Impact factor: 28.824

4.  Role of phosphatidylinositol 3,4,5-trisphosphate (PIP3) 5-phosphatase skeletal muscle- and kidney-enriched inositol polyphosphate phosphatase (SKIP) in myoblast differentiation.

Authors:  Takeshi Ijuin; Tadaomi Takenawa
Journal:  J Biol Chem       Date:  2012-07-19       Impact factor: 5.157

Review 5.  The impact of phosphoinositide 5-phosphatases on phosphoinositides in cell function and human disease.

Authors:  Ana Raquel Ramos; Somadri Ghosh; Christophe Erneux
Journal:  J Lipid Res       Date:  2018-09-07       Impact factor: 5.922

6.  Regulation of insulin signaling and glucose transporter 4 (GLUT4) exocytosis by phosphatidylinositol 3,4,5-trisphosphate (PIP3) phosphatase, skeletal muscle, and kidney enriched inositol polyphosphate phosphatase (SKIP).

Authors:  Takeshi Ijuin; Tadaomi Takenawa
Journal:  J Biol Chem       Date:  2012-01-15       Impact factor: 5.157

7.  Multiplexable fluorescence lifetime imaging (FLIM) probes for Abl and Src-family kinases.

Authors:  Sampreeti Jena; Nur P Damayanti; Jackie Tan; Erica D Pratt; Joseph M K Irudayaraj; Laurie L Parker
Journal:  Chem Commun (Camb)       Date:  2020-10-09       Impact factor: 6.222

8.  Therapeutic potential of SH2 domain-containing inositol-5'-phosphatase 1 (SHIP1) and SHIP2 inhibition in cancer.

Authors:  Gwenny M Fuhler; Robert Brooks; Bonnie Toms; Sonia Iyer; Elizabeth A Gengo; Mi-Young Park; Matthew Gumbleton; Dennis R Viernes; John D Chisholm; William G Kerr
Journal:  Mol Med       Date:  2012-02-10       Impact factor: 6.354

9.  Increased insulin action in SKIP heterozygous knockout mice.

Authors:  Takeshi Ijuin; Y Eugene Yu; Kiyohito Mizutani; Annie Pao; Sanshiro Tateya; Yoshikazu Tamori; Allan Bradley; Tadaomi Takenawa
Journal:  Mol Cell Biol       Date:  2008-06-23       Impact factor: 4.272

10.  Evidence that inositol polyphosphate 4-phosphatase type II is a tumor suppressor that inhibits PI3K signaling.

Authors:  Christina Gewinner; Zhigang C Wang; Andrea Richardson; Julie Teruya-Feldstein; Dariush Etemadmoghadam; David Bowtell; Jordi Barretina; William M Lin; Lucia Rameh; Leonardo Salmena; Pier Paolo Pandolfi; Lewis C Cantley
Journal:  Cancer Cell       Date:  2009-08-04       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.